School of Biological & Chemical Engineering, Zhejiang University of Science & Technology, Hangzhou, 310023, P. R. China.
Zhejiang Engineering Research Center for Biomedical Materials, Cixi Institute of Biomedical Engineering, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315300, P. R. China.
Chem Biodivers. 2023 Apr;20(4):e202300146. doi: 10.1002/cbdv.202300146. Epub 2023 Mar 15.
Febrifugine is a kind of quinazolinone compound with high biological activity from a Chinese herb called Chang Shan (Dichroa febrifuga). Febrifugine and its derivatives possess extensive biological activities, some of which exhibited anti-tumor activities as FAK inhibitors. However, they are not very effective at inhibiting tumor metastasis, perhaps because tumors gain energy through compensatory activation of other signaling pathways that promote cell migration and invasion. Therefore, seventeen novel febrifugine derivatives with quinazolinone skeleton were designed, synthesized and acted as potential FAK/PLK1 dual inhibitors. These compounds were determined by H-NMR, C-NMR and MS. Most of the compounds exhibited good inhibitory activity against cancer cell lines by computer-assisted screening, antitumor activity test and FAK/PLK1 inhibitory activity test, wherein compound 3b was screened as a high-efficiency lead compound.
菲布嗪是一种具有高生物活性的喹唑酮类化合物,来源于中国草药常山(Dichroa febrifuga)。菲布嗪及其衍生物具有广泛的生物活性,其中一些作为 FAK 抑制剂表现出抗肿瘤活性。然而,它们在抑制肿瘤转移方面的效果并不十分显著,这可能是因为肿瘤通过其他信号通路的代偿性激活来获取能量,这些信号通路促进细胞迁移和侵袭。因此,设计、合成了十七种具有喹唑酮骨架的新型菲布嗪衍生物,并将其作为潜在的 FAK/PLK1 双重抑制剂。这些化合物通过 1H-NMR、13C-NMR 和 MS 进行了确定。通过计算机辅助筛选、抗肿瘤活性试验和 FAK/PLK1 抑制活性试验,大多数化合物对癌细胞系表现出良好的抑制活性,其中化合物 3b 被筛选为高效的先导化合物。